Mirna Therapeutics Closes $34.5M
Mirna Therapeutics Inc., a biopharmaceutical company developing therapeutics in cancer, has raised a $34.5 million Series C financing. Sofinnova Ventures led the round, with participation from investors including New Enterprise Associates, Pfizer Ventures, Osage University Partners, and Correlation Ventures.
24 October 2012•3 mins read
